Wockhardt Ltd.
Snapshot View

197.85 -6.60 ▼-3.2%

27 January 2023, 04:01:00 PM
Volume: 57,207

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.wockhardt.com
Market Cap 2,850.23 Cr.
Enterprise Value(EV) 4,485.23 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -36.15 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share 242.54 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.82 Calculated using Price: 197.85
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 14.41 Cr. 144,060,153 Shares
FaceValue 5
Company Profile
The company is a pharmaceutical and biotechnology company. The Company's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. It has many research centres and several manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. It is a business in transition. New and innovative business models are in motion to make the most of emerging opportunities. A new drive for growth today permeates every mind-set, process and techno-innovation within Wockhardt.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.23%
1 Week
-9.03%
1 Month
-11.99%
3 Month
-17.39%
6 Month
-8.15%
1 Year
-45.46%
2 Year
-55.87%
5 Year
-76.44%
10 Year
-86.81%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 30.04 12.49 7.07 -6.42 -21.81 -11.43 -5.22 -9.92 -7.77
Return on Capital Employed (%) 18.98 11.25 6.87 -0.31 -5.47 -2.87 -1.11 -5.50 -1.96
Return on Assets (%) 13.36 5.84 3.25 -2.69 -7.93 -4.01 -1.80 -3.93 -3.71

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 3,581 3,715 3,775 3,337 2,852 2,675 2,672 3,376 3,849 3,494
Non Curr. Liab. 1,161 1,872 1,893 3,151 2,089 1,703 1,195 496 261 117
Curr. Liab. 1,743 1,773 1,842 1,979 2,692 2,864 3,497 3,121 3,207 3,246
Minority Int. 136 144 465 382 346 330 386 383 353 343
Equity & Liab. 6,622 7,505 7,976 8,849 7,978 7,571 7,749 7,376 7,670 7,200
Non Curr. Assets 3,266 3,983 4,024 4,314 4,599 4,756 5,320 4,951 5,081 4,938
Curr. Assets 3,356 3,522 3,952 4,535 3,380 2,815 2,401 2,425 2,589 2,262
Misc. Exp. not W/O
Total Assets 6,622 7,505 7,976 8,849 7,978 7,571 7,749 7,376 7,670 7,200

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 4,830 4,482 4,453 4,015 3,937 3,566 2,844 2,708 3,230 2,783
Other Income 84 67 66 114 177 21 60 132 20 130
Total Income 4,915 4,548 4,519 4,129 4,114 3,587 2,904 2,840 3,250 2,913
Total Expenditure -3,851 -3,772 -3,959 -4,002 -3,992 -3,604 -2,746 -2,771 -2,932 -2,677
PBIDT 1,064 776 560 127 122 -17 158 69 318 236
Interest -83 -55 -129 -225 -255 -265 -276 -249 -299 -309
Depreciation -140 -145 -142 -149 -150 -164 -224 -246 -247 -250
Taxation -48 -163 -38 21 -26 135 204 271 132 110
Exceptional Items 50 -358 -142 -183 -378
PAT 843 413 252 -226 -667 -312 -138 -297 -279 -591
Minority Interest -2 -8 -2 30 59 22 -26 -2 35 70
Share Associate 0 1
Other Related Items -139
Consolidated Net Profit 702 405 251 -196 -608 -195 -69 686 -244 -521
Adjusted EPS 59 34 21 -16 -51 -16 -6 57 -17 -36

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1,532 1,476 355 72 -269 68 183 649 -287 413
Cash Fr. Inv. 1,085 -852 -207 -818 -687 630 95 -156 1,470 -201
Cash Fr. Finan. -2,246 -601 -76 254 1,254 -769 -776 -680 -1,171 -71
Net Change 372 23 73 -492 298 -71 -499 -186 12 141
Cash & Cash Eqvt 1,050 1,102 1,159 665 964 897 397 219 232 370

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 72.12 72.12 69.68 68.04 67.13 67.13 65.75 63.83 60.36
Public 27.88 27.88 30.32 31.96 32.87 32.87 34.25 36.17 39.64
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 10.14 18.71 34.44 41.99 47.32 43.60 47.84 52.77 56.08

Announcements View Details >>

Wed, 18 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Loss of Certificate
Mon, 16 Jan 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for SBICAP Trustee Company Ltd
Thu, 12 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate in terms of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the quarter ended on 31st December 2022.

Technical Scans View Details >>

Fri, 27 Jan 2023
Close Crossing 52 Week Low Close Crossing 52 Week Low
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Wockhardt Ltd.

What is Wockhardt share price?

Can I buy Wockhardt shares now?

What is the Market Cap of Wockhardt?

What are the key metrics to analyse Wockhardt?

What is the 52 Week High and Low of Wockhardt?

What is the trend of Wockhardt share price?